OnAsset's security and cold-chain monitoring devices will feed real-time data through AT&T's global wireless network
For pharma manufacturers that want step-by-step tracking of cold-chain shipments (or just to monitor any shipment in transit), OnAsset Intelligence (Irving, TX) has now struck a partnership with AT&T (Dallas) whereby the former’s Sentry 400 Flight Safe datalogger and Vision platform (a cloud-based reporting system) will be integrated with AT&T’s wireless network. Both companies will market the asset-tracking service, and next-generation dataloggers are in the works.
OnAsset was one of the early offerings of small devices that both take condition readings (temperature, pressure, shock and vibration, light/dark and humidity, among others) and combine them with cellular communications capability. The result is an asset tracking system that can automatically communicate status to logistics providers or shippers. Although it’s being called real-time reporting, the service cannot communicate during a flight (FAA requirements preclude radio transmissions of aircraft in flight), and in fact the ability to automatically shut off when a flight begins and then turn on again when the plane lands is a desired feature of the technology.
The AT&T partnering isn’t OnAsset’s first; it had a prior relationship (now ended) with the Sprint communications network. OnAsset also has partnered with several air carriers and is the underlying technology for Southwest Air Cargo’s Cargo Companion service. OnAsset also recently announced a similar arrangement with Envirotainer, developers of popular unit-load devices (ULDs) that can carry pallet-sized cargo in wide-body aircraft. Adam Crossno, CEO of OnAsset, says that shippers have an increased flexibility in accessing shipment-tracking services from carriers, from security monitoring firms, from telecomm companies, or with their own internal logistics departments. “The life sciences industry is still educating itself about the value of real-time tracking,” he says, “but having gone through multiple rounds of testing and qualification with it, we are now seeing tremendous uptake of this technology.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.